Bellevue Group’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $43.6M | Buy |
|
|||||
|
2025
Q2 | $28.5M | Buy |
|
|||||
|
2025
Q1 | $19.3M | Hold |
|
|||||
|
2024
Q4 | $30.4M | Buy |
|
|||||
|
2024
Q3 | $52.2M | Buy |
|
|||||
|
2024
Q2 | $41.6M | Buy |
|
|||||
|
2024
Q1 | $49.2M | Sell |
|
|||||
|
2023
Q4 | $65.4M | Buy |
|
|||||
|
2023
Q3 | $41.1M | Buy |
|
|||||
|
2023
Q2 | $52.4M | Sell |
|
|||||
|
2023
Q1 | $68.7M | Sell |
|
|||||
|
2022
Q4 | $62.8M | Hold |
|
|||||
|
2022
Q3 | $94.1M | Buy |
|
|||||
|
2022
Q2 | $67.5M | Buy |
|
|||||
|
2022
Q1 | $117M | Sell |
|
|||||
|
2021
Q4 | $126M | Buy |
|
|||||
|
2021
Q3 | $118M | Buy |
|
|||||
|
2021
Q2 | $96.6M | Buy |
|
|||||
|
2021
Q1 | $66.8M | Buy |
|
|||||
|
2020
Q4 | $58.6M | Buy |
|
|||||
|
2020
Q3 | $55.4M | Buy |
|